Literature DB >> 17151795

Selective application of axillary node dissection in elderly women with early breast cancer.

Dalal Aziz1, Sandra Gardner, Kathleen Pritchard, Lawrence Paszat, Claire M B Holloway.   

Abstract

BACKGROUND: Routine use of axillary lymph node dissection (ALND) has been questioned in elderly women. This study examines whether selective application of ALND in early stage breast cancer affects breast cancer-related survival.
METHODS: From the Surveillance, Epidemiology, and End Results (SEER) database, records of women >or=70 years of age with stage I or II breast cancer diagnosed between 1990 and 1995 were reviewed. Hazard ratios (HR) of cause-specific survival (CSS) between women receiving ALND and those who did not were compared. To minimize the potential for bias in the selection of women to receive ALND, HR of CSS was compared within propensity analysis deciles.
RESULTS: 20,151 women entered the analysis. Median follow up was 6 years (interquartile range 4.33-7.67 years). Seventy-five percent underwent ALND. Women with higher risk disease and younger age were more likely to undergo ALND. Five year unadjusted CSS in women who did and did not receive ALND was 92.1% and 90.6%, respectively, with a HR of 0.85, P = 0.002. Using the propensity analysis method, the adjusted HR for CSS associated with ALND was 0.89, P = 0.066. DISCUSSION: After adjusting for differences in the probability of receiving ALND, no clinically or statistically significant difference in survival was observed among women who received ALND when compared with those who did not, although we could not account for differences in co-morbidity or use of systemic therapy between groups.
CONCLUSION: Surgeons select elderly women with early stage breast cancer for ALND with a negligible impact on CSS.

Entities:  

Mesh:

Year:  2006        PMID: 17151795     DOI: 10.1245/s10434-006-9092-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.

Authors:  Elaine McKevitt; Rona Cheifetz; Kimberly DeVries; Alison Laws; Rebecca Warburton; Lovedeep Gondara; Caroline Lohrisch; Alan Nichol
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

2.  Predictors and outcomes of completion axillary node dissection among older breast cancer patients.

Authors:  Sara H Javid; Hao He; Larissa A Korde; David R Flum; Benjamin O Anderson
Journal:  Ann Surg Oncol       Date:  2014-03-01       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.